HealthEquity, Inc. $HQY Shares Bought by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 53.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 44,600 shares of the company’s stock after acquiring an additional 15,600 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al owned 0.05% of HealthEquity worth $3,945,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. BlackRock Inc. bought a new position in HealthEquity in the 2nd quarter valued at $1,018,621,000. Wasatch Advisors LP increased its position in shares of HealthEquity by 10.5% during the 2nd quarter. Wasatch Advisors LP now owns 7,960,735 shares of the company’s stock valued at $719,014,000 after purchasing an additional 757,801 shares during the last quarter. William Blair Investment Management LLC purchased a new stake in shares of HealthEquity during the 2nd quarter valued at $160,158,000. Dimensional Fund Advisors LP raised its stake in shares of HealthEquity by 2.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,627,039 shares of the company’s stock worth $135,957,000 after purchasing an additional 45,287 shares during the period. Finally, Bank of America Corp DE bought a new stake in shares of HealthEquity during the 2nd quarter worth $103,573,000. 99.55% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other HealthEquity news, Director Adrian Dillon sold 7,632 shares of the firm’s stock in a transaction dated Tuesday, August 25th. The stock was sold at an average price of $104.61, for a total value of $798,383.52. Following the sale, the director owned 62,395 shares of the company’s stock, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

Shares of HQY stock opened at $102.47 on Monday. The company’s fifty day simple moving average is $95.37 and its two-hundred day simple moving average is $89.04. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $107.62. The stock has a market capitalization of $8.48 billion, a price-to-earnings ratio of 36.99, a PEG ratio of 1.62 and a beta of 0.22.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Thursday, August 27th. The company reported $1.24 EPS for the quarter, topping analysts’ consensus estimates of $1.19 by $0.05. The firm had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. HealthEquity’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 3.94 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of research analyst reports. Telsey Advisory Group set a $111.00 price target on shares of HealthEquity in a report on Friday, August 28th. Raymond James Financial restated a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd. Weiss Ratings raised shares of HealthEquity from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, October 16th. Barclays boosted their target price on shares of HealthEquity from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Friday, September 18th. Finally, Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $113.53.

About HealthEquity

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.